Skip to main content
Staff Login
Username
*
Enter your The Contraceptive Pipeline Database username.
Password
*
Enter the password that accompanies your username.
Log in
Forgot password
Toggle navigation
HER-102
Product Overview
Alternative Name:
Lactobacilli, LJ-102
Development Status:
Active Development
Target:
Female
Mode:
Non-hormonal
Delivery Type:
Vaginal, Other
Duration Type:
Short-acting
Description:
Lactobacilli are a dominant genera (probiotic) that resides in the female reproductive tract. Lactobacilli promotes resistance to pathogenic microorganisms and promotes maturation and integrity of the genital tract. The lactobacilli administers an agent, interfering with fertilization. As a vaginally applied formulation once or bi-monthly, the contraceptive will persist for long periods.
Updated date:
May 30, 2018
Vertical Tabs
Product Details
Active Pharmaceutical Ingredient (API):
lactobacilli
Potential Multi-Purpose Technology (MPT):
Yes
Regimen:
Once or twice a month
Duration:
Persistence following application until menses
Partner:
Hervana Bio
Status
Project Phase:
Early Development
Project Stage:
Lead Optimization
Began discovery in:
2010
Status Details:
Received grants in 2010 and 2012 from the Bill & Melinda Gates Foundation.
Programmatic Considerations
Considerations:
The contraceptive is fully reversible and completely bypasses the hormone axis.
Additional Information
Additional Information:
Hervana Bio website
Download Product Report
